Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Robinson's H1 profits surge, but trading conditions still 'challenging'

(Sharecast News) - Plastic and paperboard packaging group Robinson saw profits more than double in the first half despite subdued top-line performance, but the company delivered a cautious outlook for demand. The Chesterfield-based firm reported a pre-tax profit of £1.8m over the six months to 30 June, up from £0.7m the year before, with gross margins rising to 22% from 21%, due to the recovery of previous inflation through sales prices and reductions in some input costs.

Profits the previous year were also weighed down by £0.5m of charges for the amortisation and impairment of intangible assets, of which this year there are none.

Revenues for the period were up 2% year-on-year at £27.6m, though sales volumes were flat with growth held back by falling volumes in Denmark, which saw "significantly lower and more volatile demand from our larger customers, loss of some contracts and overall, trading conditions in that territory remain challenging", Robinson said.

Looking ahead, chair Alan Raleigh said market conditions "remain challenging" and Robinson continues to see "softness and volatility in demand from some existing customers".

However, the company said it has seen an improved sales pipeline, helped by its partnerships with major FMCG customers.

Meanwhile, Robinson, which is selling off "surplus property" to cut debt levels and create a more streamlined business, said that it now has agreements in place to dispose more than 70% of its portfolio by value. Net debt increased to £8.5m by the end of the period, up from £5.9m at the end of 2024.

The stock was down 8.3% at 142.1p by 0914 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.